Summary - IBIO - NASDAQ - Weiss Ratings

D

iBio, Inc. IBIO

$2.22 $0.115.21% NASDAQ

Recommendation

Dividend Power Score

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

--

52-Week Range

$0.56 - $6.89

P/E (TTM)

--

EPS (TTM)

My Lists My Alerts

HealthTech & Bioinformatics Biotechnology Health Care Pharmaceutical

Access our Premium Ratings

Get Access

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Yield Index

Headlines

iBio (NASDAQ:IBIO) Rating Lowered to Sell at Wall Street Zen

2/14/2026 - MarketBeat

iBio Earnings Review: Q2 Summary

2/10/2026 - Benzinga

iBio GAAP EPS of -$0.09

2/10/2026 - Seeking Alpha - Healthcare

iBio reports Q2 EPS (9c), consensus (6c)

2/10/2026 - The Fly

iBio reports Q2 EPS (9c), consensus (6c)

2/10/2026 - The Fly

iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update

2/10/2026 - Globe Newswire

CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: Should You Buy?

2/3/2026 - Zacks Investment Research

iBio, Inc. (IBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

2/2/2026 - Zacks Investment Research

iBio files to sell 11.06M shares of common stock for holders

1/30/2026 - TipRanks Financial Blog

iBio files to sell 11.06M shares of common stock for holders

1/30/2026 - The Fly

iBio (NASDAQ:IBIO) Stock Price Down 3.6% - Here's Why

1/30/2026 - MarketBeat

Thursday Sector Laggards: Drugs, Biotechnology Stocks

1/15/2026 - Nasdaq News: Stocks

Video: Thursday Sector Laggards: Drugs, Biotechnology Stocks

1/15/2026 - Market News Video

iBio (NYSE:IBIO) Stock Price Down 5.9% - Here's What Happened

1/14/2026 - MarketBeat

iBio Announces Private Placement to Fund Pipeline Expansion

1/12/2026 - TipRanks Financial Blog

iBio (NYSEMKT:IBIO) Trading 8.3% Higher - Here's Why

1/10/2026 - MarketBeat

iBio (IBIO) Secures $26M in Private Placement Financing

1/9/2026 - GuruFocus

iBio announces private placement financing to raise ~$26M

1/9/2026 - Seeking Alpha - Healthcare

iBio (IBIO) Secures $26M Financing to Advance Cardiometabolic Programs

1/9/2026 - GuruFocus

IBIO Stock Soars 12% Pre-Market After Company Announces $26 Million Private Placement

1/9/2026 - Stocktwits News Feed

iBio prices 11.06M shares at $2.35 in private placement

1/9/2026 - The Fly

iBio Announces $26 Million Private Placement

1/9/2026 - GuruFocus

iBio Announces $26 Million Private Placement

1/9/2026 - Globe Newswire

iBio, Inc. (NASDAQ:IBIO) Short Interest Update

12/29/2025 - Ticker Report

Ibio, RLMD, SEE, OLLI, Invivyd Trending With Analysts

12/27/2025 - TipRanks Financial Blog

Income Statement

Total Revenue (TTM)

EBITDA (TTM)

EBIT (TTM)

Net Income (TTM)

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

Cash from Investing (TTM)

Cash from Financing (TTM)

Net Change in Cash (TTM)

Filings

Filing Date

Tuesday, February 10, 2026

Period Date

Wednesday, December 31, 2025

Next Filing

Beginning of May (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

52-week Low

Aug 08, 2025 - $0.56

52-week High

Mar 03, 2025 - $6.89

Valuation

Market Cap

$72.89M - Micro Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

--

Dividend Per Share (TTM)

--

Corporate Info

Website

Phone Number

979 446 0027

Address

11750 Sorrento Valley Road
San Diego, CA 92121

Country

Year Founded

Business Description

Sector

Industry

Pharmaceuticals, Biotechnology and Life Sciences

iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space. The company’s... more